Merck & Co., Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (Sept. 1, 2026).
Saved in:
| Title: | Merck & Co., Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (Sept. 1, 2026). |
|---|---|
| Source: | Pharma Business Week. 9/18/2026, p1687-1687. 1p. |
| Database: | Business Source Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Text: Availability: 1 |
|---|---|
| Header | DbId: bsu DbLabel: Business Source Ultimate An: 196958808 AccessLevel: 2 PubType: Periodical PubTypeId: serialPeriodical PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Merck & Co., Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (Sept. 1, 2026). – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Pharma+Business+Week%22">Pharma Business Week</searchLink>. 9/18/2026, p1687-1687. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=bsu&AN=196958808 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: 1687 Titles: – TitleFull: Merck & Co., Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (Sept. 1, 2026). Type: main BibRelationships: IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 09 Text: 9/18/2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 15436675 Titles: – TitleFull: Pharma Business Week Type: main |
| ResultId | 1 |